Related Experiment Videos

Identification of the MDM2 oncoprotein as a substrate for CPP32-like apoptotic proteases

P Erhardt1, K J Tomaselli, G M Cooper

  • 1Division of Molecular Genetics, Dana-Farber Cancer Institute and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.

Insights

Members of the interleukin 1-beta convertase protease family cleave the MDM2 oncoprotein during programmed cell death. This cleavage may deregulate the p53 tumor suppressor, contributing to apoptosis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Programmed cell death, or apoptosis, is crucial for development and tissue homeostasis.
  • Interleukin 1-beta convertase (ICE)-family proteases are key mediators of apoptosis.
  • The specific substrates of these proteases driving apoptosis remain largely unidentified.

Purpose of the Study:

  • To identify key substrates of ICE-family proteases involved in apoptotic cell death.
  • To investigate the interaction between MDM2 oncoprotein and CPP32-like proteases in apoptosis.

Main Methods:

  • In vitro protease assays to assess MDM2 cleavage by CPP32-like proteases.
  • In vivo studies in apoptotic cells to observe MDM2 disappearance.
  • Analysis of the regulatory relationship between MDM2, p53, and apoptosis.

Main Results:

  • MDM2 oncoprotein is directly cleaved by CPP32 subfamily proteases.
  • Cleavage of MDM2 by CPP32-like proteases leads to its disappearance from apoptotic cells.
  • MDM2 negatively regulates the p53 tumor suppressor, which induces apoptosis.

Conclusions:

  • Cleavage of MDM2 by CPP32-like proteases is a significant event in apoptosis.
  • This cleavage may lead to the deregulation of p53 tumor suppressor function.
  • The MDM2-p53 pathway is a critical target in understanding and potentially manipulating apoptotic cell death.

Related Concept Videos